Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine added to ropivacaine for axillary block in upper limb surgery
IRCT20221017056211N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in None comparing Intervention: ropivacaine + neostigmine with Control: ropivacaine + placebo (2 arms). Primary endpoints: Regional anesthesia onset time, Regional anesthesia effect intensity and 1 more. Started Oct 2022; status: completed.
02
Drugs
neostigmineropivacaine
Beyond the preview
Go deeper on IRCT20221017056211N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221017056211N1.